IPOD

Chamath Palihapitiya’s Crumbling SPAC Empire: Where His Top 5 Deals Are Today

By Dana Blankenhorn, InvestorPlace Contributor
None of the companies the King of SPACs Chamath Palihaitiya took public has made money for investors, although one still has a chance.

Chamath Palihapitiya Is Giving Up on IPOF, IPOD Stocks

By Eddie Pan, InvestorPlace Financial News Writer
Both IPOF stock and IPOD stock are now trading at their IPO prices of $10 after Palihapitiya pulled the plug on the SPACs.

3 SPAC Stocks at Risk of Failing Like PSTH

By Samuel O'Brient, InvestorPlace Reporter
Bill Ackman's recent announcement may be the end of the SPAC boom. Here are the SPAC stocks that investors should be staying away from.

7 SPACs That Need To Find Their Dance Partner Before Time Runs Out

By Faizan Farooque, InvestorPlace Contributor
SPACs are popping up in SEC filings left, right, and center. Here are seven excellent prospects on the lookout for merger targets.

IPOF Stock: What to Know About the New Equinox SPAC Merger Rumors

By Robert Lakin, InvestorPlace Contributor
IPOF stock is on the move Wednesday following rumors that Chamath Palihapitiya could be leading an Equinox SPAC merger.

Wait and See When It Comes to Social Capital Hedosophia Holdings Stock

By Stavros Georgiadis, CFA, InvestorPlace Contributor
The risks are simply too high to buy IPOD stock at this point. My best advice on SPACs like this? Stay in wait-and-see mode for now.

Palihapitiya’s Track Record Makes IPOD Stock a Must-Buy

By Faizan Farooque, InvestorPlace Contributor
IPOD stock has an ace sponsor, which counts for a lot in the volatile world of SPAC investing. Buy this one before the inevitable merger.

When Social Capital Hedosophia Holdings IV Names A Partner, IPOD Stock Could Become Another Winner

By Tezcan Gecgil, InvestorPlace Contributor
As IPOD stock is currently trading at a premium, it is a high risk high return play.

Hit the Skip Button on IPOD Stock for Now

By Ian Bezek, InvestorPlace Contributor
Chamath Palihapitiya is a very busy man. This could cause issues for IPOD stock in the short run as traders turn elsewhere.

5 SPACs That Could Go Wrong

By Vince Martin, InvestorPlace Contributor
Nothing is riskier than getting in at the end of a trend — and SPACs have been a huge trend. These 5 could have big downside when the music stops.

IPOF Stock: Why Chamath Palihapitiya’s SPACs Are Soaring Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
IPOF stock and sibling IPOD stock are both on the move after Chamath Palihapitiya fueled SPAC speculation on Twitter. Here's what to know.

Social Capital Hedosophia Holdings IV Belongs on Your SPAC To-Do List

By David Moadel, InvestorPlace Contributor
Chamath Palihapitiya is well-known for making magic out of blank-check companies, and IPOD stock could be another success story.

Don’t Buy Overvalued and Speculative SPACs Like IPOD Stock

By Mark R. Hake, CFA
Don't buy overvalued SPACs like IPOD stock. IPOD stock trades for over 75% more than its IPO price even though there is no merger deal.

Top SPAC Merger News This Week: SoFi, Clover Health, Lion Electric and 6 More Hot SPACs

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
There was a lot of SPAC merger news for investors to digest this week. For a quick refresher, dive in with InvestorPlace.

SPAC Merger News: Why IPOD, IPOE and IPOF Stock Are on the Move Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com
Chamath Palihapitiya announced IPOE would take SoFi public. Now that SPAC merger news has IPOD and IPOF stock soaring.